We are live on ! Find out more
XBIT icon

XBiotech
XBIT

34 hedge funds and large institutions have $11.4M invested in XBiotech in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

10% more funds holding

Funds holding: 31 → 34 (+3)

8% more capital invested

Capital invested by funds: $10.6M → $11.4M (+$819K)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$936K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$856K
3
Northern Trust
Northern Trust
Illinois
+$783K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$698K
5
AA
ALPS Advisors
Colorado
+$325K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$477K
2
Morgan Stanley
Morgan Stanley
New York
-$227K
3
BFA
BlackRock Fund Advisors
California
-$19.9K
4
Millennium Management
Millennium Management
New York
-$9.7K
5
UBS Group
UBS Group
Switzerland
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.76M +$856K +48,883 +24%
BFA
2
BlackRock Fund Advisors
California
$1.56M -$19.9K -1,137 -1%
Goldman Sachs
3
Goldman Sachs
New York
$799K +$936K +53,462 New
FHC
4
Forest Hill Capital
Arkansas
$672K – – –
Northern Trust
5
Northern Trust
Illinois
$668K +$783K +44,739 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$596K +$698K +39,896 New
BIT
7
BlackRock Institutional Trust
California
$495K +$141K +8,049 +32%
MHS
8
M Holdings Securities
Oregon
$401K +$233K +13,333 +99%
State Street
9
State Street
Massachusetts
$349K +$38.2K +2,185 +10%
BFG
10
Beacon Financial Group
Texas
$321K – – –
SF
11
Synovus Financial
Georgia
$264K +$309K +17,672 New
BIM
12
BlackRock Investment Management
Delaware
$208K -$4.97K -284 -2%
Charles Schwab
13
Charles Schwab
California
$203K +$237K +13,542 New
TCIM
14
TIAA CREF Investment Management
New York
$188K – – –
Bank of New York Mellon
15
Bank of New York Mellon
New York
$187K +$39.9K +2,282 +22%
Millennium Management
16
Millennium Management
New York
$186K -$9.7K -554 -4%
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$110K – – –
Morgan Stanley
18
Morgan Stanley
New York
$102K -$227K -12,971 -65%
TA
19
Teachers Advisors
New York
$85K – – –
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$55K +$16.7K +956 +35%
NFA
21
Nationwide Fund Advisors
Ohio
$39K – – –
AIG
22
American International Group
New York
$35K +$35 +2 +0.1%
BA
23
BlackRock Advisors
Delaware
$30K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$30K +$21.3K +1,217 +143%
SO
25
STRS Ohio
Ohio
$19K – – –
1
2

XBIT Hedge Fund Activity: Q3 2015 in Review

34 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q3 2015, worth a combined $11.4M — up 7.7% from $10.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new XBIT positions and 3 closed out — a net gain of 3 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $936K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $477K sold.

  • 34 institutional investors held XBiotech (XBIT) as of Q3 2015, up from 31 in Q2 2015.
  • Funds reported $11.4M of XBiotech stock for Q3 2015, up 7.7% quarter-over-quarter.
  • 6 funds opened new XBiotech positions in Q3 2015 and 3 closed out, a net change of +3 holders.
  • The largest XBiotech buyer in Q3 2015 was Goldman Sachs, an estimated $936K added.
  • The largest XBiotech seller in Q3 2015 was Virtu KCG Holdings, an estimated $477K sold.

Based on aggregated 13F filings for Q3 2015.